24 Followers on Owler

Arvinas

develops and commercializes small molecular therapeutics for the treatment of pro-inflammatory and autoimmune diseases... Read more
OverviewCompetitorsFundingNews & Insights

Arvinas

develops and commercializes small molecular therapeutics for the treatment of pro-inflammatory and autoimmune diseases... Read more
Arvinas President & CEO: John G. Houston

President & CEO

John G. Houston

CEO Approval Rating

90/100

2013

PublicNASDAQARVN

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals
2836 NAICS listing

Annual Revenue
$263.4M
Employees
420
Funding
$268.4M

News

Conference Presentation
Nov 27, 2024
Yahoo
Arvinas to Present at Piper Sandler 36th Annual Healthcare Conference

Arvinas Competitors

1Perthera
2Pyxis Oncology
3IFM Therapeutics
4Jounce
5NexImmune
6Enlivex
7Exagen
8bluebird bio
9Aura
10Lycia Therapeutics
Unlock 11 + competitors

Trending Companies